The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Huang Jane since year 2005.
The trader's CIK number is 1683913.
At the time of the last reporting, Huang Jane was the CMO, Hematology of Beigene, Ltd. .
(stock ticker symbol BGNE).
See this page for all insider trading activities at Beigene, Ltd. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-04-08||BGNE||Beigene, Ltd.||Option Ex||14,130||29.49||416,693|
|2019-03-11||BGNE||Beigene, Ltd.||Option Ex||2,565||29.49||75,641|
|2018-11-26||BGNE||Beigene, Ltd.||Option Ex||3,000||29.49||88,470|
|2017-12-21||BGNE||Beigene, Ltd.||Option Ex||1,000||29.51||29,510|
|2017-12-13||BGNE||Beigene, Ltd.||Option Ex||1,500||29.51||44,265|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Huang Jane (CMO, Hematology of Beigene, Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.